Page last updated: 2024-08-23

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cancer of Nasopharynx

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alajez, NM; Bastianutto, C; Gullane, P; Hui, AB; Liu, FF; Lo, KW; Ng, R; O'Sullivan, B; Shi, W; Yue, S1

Other Studies

1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cancer of Nasopharynx

ArticleYear
Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.
    Cell death and differentiation, 2009, Volume: 16, Issue:11

    Topics: Animals; Apoptosis; Chromans; Disease Progression; Gene Expression Profiling; Gene Knockdown Techniques; Histones; Humans; Mice; Microarray Analysis; Nasopharyngeal Neoplasms; Nuclear Proteins; Polycomb Repressive Complex 1; Proto-Oncogene Proteins; Reactive Oxygen Species; Repressor Proteins; RNA, Messenger; RNA, Small Interfering; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2009